Evidence map›Paper›PMID 39074615›Full record

ArticleMucosal immunology2024

Distinct olfactory mucosal macrophage populations mediate neuronal maintenance and pathogen defense.

Sebastian A Wellford, Ching-Wen Chen, Marko Vukovic, Kristen A Batich, Elliot Lin, Alex K Shalek, Jose Ordovas-Montanes, Annie Park Moseman, E Ashley Moseman

Abstract read
In one paragraph

Article in Mucosal immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Olfactory immunity: defending the neural-mucosal barrier.Journal of immunology (Baltimore, Md. : 1950) · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sebastian A WellfordDepartment of Integrative Immunobiology, Duke University School of Medicine, Durham, NC, United States; Cell Signaling and Immunity Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Ching-Wen ChenDepartment of Integrative Immunobiology, Duke University School of Medicine, Durham, NC, United States.
Marko VukovicBroad Institute of MIT and Harvard, Cambridge, MA, United States; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, United States; Institute for Medical Engineering and Science (IMES), MIT, Cambridge, MA, United States; Department of Chemistry, MIT, Cambridge, MA, USA.
Kristen A BatichDepartment of Integrative Immunobiology, Duke University School of Medicine, Durham, NC, United States; Department of Neurosurgery, Duke University School of Medicine, Durham, NC, United States.
Elliot LinDepartment of Integrative Immunobiology, Duke University School of Medicine, Durham, NC, United States.
Alex K ShalekBroad Institute of MIT and Harvard, Cambridge, MA, United States; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, United States; Institute for Medical Engineering and Science (IMES), MIT, Cambridge, MA, United States; Department of Chemistry, MIT, Cambridge, MA, USA; Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, United States.
Jose Ordovas-MontanesBroad Institute of MIT and Harvard, Cambridge, MA, United States; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, United States; Division of Gastroenterology, Hepatology, and Nutrition, Boston Children's Hospital, Boston, MA, United States; Harvard Stem Cell Institute, Cambridge, MA, United States; Program in Immunology, Harvard Medical School, Boston, MA, United States.
Annie Park MosemanDepartment of Integrative Immunobiology, Duke University School of Medicine, Durham, NC, United States.
E Ashley MosemanDepartment of Integrative Immunobiology, Duke University School of Medicine, Durham, NC, United States. Electronic address: ashley.moseman@duke.edu.

Funding

Medical Scientist Training Program Training GrantT32GM145449 · NIGMS · DUKE UNIVERSITY · PI Christopher D Kontos · 2022 to 2026
$6.6M
Basic Immunology Training ProgramT32AI052077 · NIAID · DUKE UNIVERSITY · PI KRANGEL, MICHAEL S · 2002 to 2024
$4.2M
Balancing epithelial cell resistance and resilience to respiratory viral infectionsR01HL162642 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI Jose Manuel Ordovas-Montanes · 2023 to 2026
$3.4M
"Bottom - Up" Profiling of Interacting Cellular SystemsDP2GM119419 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI SHALEK, ALEX K · 2015 to 2015
$2.3M
Treatment of Primary Amoebic Meningoencephalitis via Modulation of Antibody Effector FunctionsR01NS121067 · NINDS · DUKE UNIVERSITY · PI MOSEMAN, E. ASHLEY · 2021 to 2025
$2.0M
Infectious Influence: Using fate mapping to determine the impact of viral infection sites on Alzheimer's disease initiationR21AG074324 · NIA · DUKE UNIVERSITY · PI MOSEMAN, E. ASHLEY · 2021 to 2022
$439k
T cell/astrocyte fusions as a novel form of trained immunity to infectionR21NS133561 · NINDS · DUKE UNIVERSITY · PI MOSEMAN, E. ASHLEY · 2023 to 2024
$434k
Defining the molecular and anatomical basis of the blood-olfactory barrier (BOB)R21DC021260 · NIDCD · DUKE UNIVERSITY · PI MOSEMAN, E. ASHLEY · 2023 to 2023
$434k
NHLBI NIH HHS R01 HL162642NIAID NIH HHS T32 AI052077NIA NIH HHS R21 AG074324NIDCD NIH HHS R21 DC021260NIGMS NIH HHS DP2 GM119419NIGMS NIH HHS T32 GM145449NINDS NIH HHS R01 NS121067NINDS NIH HHS R21 NS133561
6 · The paper itself

Abstract

The olfactory mucosa is important for both the sense of smell and as a mucosal immune barrier to the upper airway and brain. However, little is known about how the immune system mediates the conflicting goals of neuronal maintenance and inflammation in this tissue. A number of immune cell populations reside within the olfactory mucosa and yet we have little understanding of how these resident olfactory immune cells functionally interact with the chemosensory environment. Identifying these interactions will allow therapeutic manipulations that treat disorders such as post-viral olfactory dysfunction. Macrophages are the most prevalent immune cell type in the uninflamed olfactory mucosa and here, we identify two distinct tissue macrophage populations in murine olfactory mucosa. P2ry12

Indexed as

COVID-19MacrophagesOlfactory MucosaAnimalsAntigen PresentationCytokinesFemaleHumansMaleMiceMice, Inbred C57BLOlfactory Receptor NeuronsPhagocytosisSARS-CoV-2Cytokines

Identifiers

PMID39074615
PMCPMC11483463

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.